AU509455B2 - 4-carbamoy-5-hydroxyimdazole to treat cancer - Google Patents

4-carbamoy-5-hydroxyimdazole to treat cancer

Info

Publication number
AU509455B2
AU509455B2 AU28619/77A AU2861977A AU509455B2 AU 509455 B2 AU509455 B2 AU 509455B2 AU 28619/77 A AU28619/77 A AU 28619/77A AU 2861977 A AU2861977 A AU 2861977A AU 509455 B2 AU509455 B2 AU 509455B2
Authority
AU
Australia
Prior art keywords
hydroxyimdazole
carbamoy
treat cancer
cancer
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU28619/77A
Other versions
AU2861977A (en
Inventor
N. Kiyotaka T. and Ogino S Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of AU2861977A publication Critical patent/AU2861977A/en
Application granted granted Critical
Publication of AU509455B2 publication Critical patent/AU509455B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28619/77A 1976-09-07 1977-09-07 4-carbamoy-5-hydroxyimdazole to treat cancer Expired AU509455B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP51107520A JPS604802B2 (en) 1976-09-07 1976-09-07 anticancer drug
JPJP107520/7 1976-09-07

Publications (2)

Publication Number Publication Date
AU2861977A AU2861977A (en) 1979-03-15
AU509455B2 true AU509455B2 (en) 1980-05-15

Family

ID=14461270

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28619/77A Expired AU509455B2 (en) 1976-09-07 1977-09-07 4-carbamoy-5-hydroxyimdazole to treat cancer

Country Status (6)

Country Link
JP (1) JPS604802B2 (en)
AU (1) AU509455B2 (en)
CA (1) CA1078736A (en)
DE (1) DE2740281A1 (en)
FR (1) FR2363329A1 (en)
NL (1) NL7709853A (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU507066B1 (en) * 1977-09-06 1980-01-31 Sumitomo Chemical Company, Limited 2-Substituted-5-Hydroxy-1h-Imidazole 4-Carbozamide Derivatives
JPS5495568A (en) * 1978-01-06 1979-07-28 Sumitomo Chem Co Ltd Novel imidazoleacetic acid derivative
AU530916B2 (en) * 1979-08-08 1983-08-04 Sumitomo Chemical Company, Limited 4-carbamoyl imidazolium-5-olate derivatives
JPS5780317A (en) * 1980-11-05 1982-05-19 Sumitomo Chem Co Ltd Preparation of pharmaceutical composition for injection
EP0051962B1 (en) * 1980-11-05 1988-08-24 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
US4464531A (en) * 1981-04-20 1984-08-07 Sumitomo Chemical Company, Limited 4-Carbamoylimidazolium-5-olate derivatives
JPS6089418A (en) * 1983-10-20 1985-05-20 Sumitomo Chem Co Ltd Sustained release carcinostatic agent
JPS60193997A (en) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd New cyanoimidazole ribonucleoside derivative and its preparation
US6750420B1 (en) * 1998-11-13 2004-06-15 Elpatronic Ag Method for welding tubes and device for carrying out said method
JP5266010B2 (en) 2007-09-14 2013-08-21 富士フイルム株式会社 4-Carbamoyl-5-hydroxy-imidazole derivative sulfonate compound
WO2014112531A1 (en) 2013-01-15 2014-07-24 富士フイルム株式会社 Package for solid preparation including 5-hydroxy-1h-imidazole-4-carboxamide or salt or hydrate thereof
EP2946780B1 (en) 2013-01-15 2017-03-01 FUJIFILM Corporation Tablet containing 5-hydroxy-1h-imidazole-4-carboxamide
JP6001684B2 (en) * 2013-01-15 2016-10-05 富士フイルム株式会社 5-hydroxy-1H-imidazole-4-carboxamide sulfate
KR101856889B1 (en) 2014-01-10 2018-05-10 후지필름 가부시키가이샤 5-hydroxy-1h-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52101855A (en) * 1976-02-21 1977-08-26 Toyo Seisakusho Kk Air moistener

Also Published As

Publication number Publication date
AU2861977A (en) 1979-03-15
FR2363329A1 (en) 1978-03-31
DE2740281A1 (en) 1978-03-09
NL7709853A (en) 1978-03-09
JPS604802B2 (en) 1985-02-06
CA1078736A (en) 1980-06-03
JPS5332124A (en) 1978-03-27
FR2363329B1 (en) 1981-01-23

Similar Documents

Publication Publication Date Title
AU505720B2 (en) Sunlamp
AU511855B2 (en) Skin treatment composition
AU1108376A (en) Polyhemoglobin
AU1006976A (en) Inhilator
AU1025376A (en) Pourer-stopper
AU1230276A (en) Amidinoureas
AU1230176A (en) Imidinoureas
AU1441776A (en) Thieno-pyridines
AU1373876A (en) Bottlecap
AU509455B2 (en) 4-carbamoy-5-hydroxyimdazole to treat cancer
AU503234B2 (en) Plow
AU1128976A (en) Magneto-alternator
AU1417076A (en) Propargyl-2 phenylamino-2-impazolines
AU506320B2 (en) Size reduction
AU1565576A (en) L- pyroglutamyl-l-prolinamide
AU504464B2 (en) Treating wood
AU498195B2 (en) Cutter
AU1408076A (en) Lysolipin Antibioties
AU514194B2 (en) Treating trees
AU1191776A (en) Fluoro-prostaglandins
AU507072B2 (en) Reducing zeearalenone
AU1393076A (en) Dihydromocimycin
AU527958B2 (en) Cancer treatment
AU1398876A (en) Aryl-di-thioureas
AU1612176A (en) Fluoro-steroids